Quercetin reduces serum homocysteine level in rats fed a methionine-enriched diet

Nutrition

Volumn 29, Issue 4, 2013, Pages 661-666

  Meng, Bin ^a,b   Gao, Weina ^a   Wei, Jingyu ^a   Yang, Jijun ^a   Wu, Jianquan ^a   Pu, Lingling ^a   Guo, Changjiang ^a  

^a INSTITUTE OF HEALTH AND ENVIRONMENTAL MEDICINE   (China)

^b Tianjin Key Laboratory for Biomarkers of Occupational and Environmental Hazard   (China)

Author keywords

Antioxidant; Homocysteine; Quercetin; Rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBONYL DERIVATIVE; CYSTEINE; GLUTATHIONE; HOMOCYSTEINE; MALONALDEHYDE; METHIONINE; QUERCETIN; SERINE; SUPEROXIDE DISMUTASE; TAURINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; HYPERHOMOCYSTEINEMIA; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DIET; RAT; THERAPY EFFECT; TISSUE LEVEL;

ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; GLUTATHIONE; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; METHIONINE; ORGAN SIZE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; QUERCETIN; RANDOM ALLOCATION; RATS; RATS, WISTAR; WEIGHT GAIN;

RATTUS;

EID: 84875372346     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.10.012     Document Type: Article

References (43)

1. Kloor D., Stumvoll W., Schmid H., Kömpf J., Mack A., Osswald H. Localization of S-adenosylhomocysteine hydrolase in the rat kidney. J Histochem Cytochem 2000, 48:211-218.
2. Ntaios G., Savopoulos C., Grekas D., Hatzitolios A. The controversial role of B-vitamins in cardiovascular risk: an update. Arch Cardiovasc Dis 2009, 102:847-854.
3. Ball R.O., Courtney-Martin G., Pencharz P.B. The in vivo sparing of methionine by cysteine in sulfur amino acid requirements in animal models and adult humans. J Nutr 2006, 136:1682S-1693S.
4. Wang X., Cui L., Joseph J., Jiang B., Pimental D., Handy D.E., et al. Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress. J Mol Cell Cardiol 2012, 52:753-760.
5. Maurer M., Burri S., de Marchi S., Hullin R., Martinelli M., Mohacsi P., et al. Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome. Int J Cardiol 2010, 141:32-38.
6. Agoston-Coldea L., Mocan T., Gatfosse M., Lupu S., Dumitrascu D.L. Plasma homocysteine and the severity of heart failure in patients with previous myocardial infarction. Cardiol J 2011, 18:55-62.
7. Szasz T., Thakali K., Fink G.D., Watts S.W. A comparison of arteries and veins in oxidative stress: products, destroyers, function, and disease. Exp Biol Med 2007, 232:27-37.
8. Chen N., Liu Y., Greiner C.D., Holzman J.L. Physiological concentrations of homocysteine inhibits the human plasma GSH peroxidase that reduces organic hydroperoxides. J Lab Clin Med 2000, 136:58-65.
9. Abraham J.M., Cho L. The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease?. Cleveland Clin J Med 2010, 77:911-918.
10. Lin P.T., Lee B.J., Chang H.H., Cheng C.H., Tsai A.J., Huang Y.C. Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients. Nutr Res 2006, 26:460-466.
11. Pfeiffer C.M., Osterloh J.D., Kennedy-Stephenson J., Picciano M.F., Yetley E.A., Rader J.I., et al. Trends in circulating concentrations of total homocysteine among US adolescents and adults: findings from the 1991-1994 and 1999-2004 national health and nutrition examination surveys. Clin Chem 2008, 54:801-813.
12. Atkinson W., Slow S., Elmslie J., Lever M., Chambers S.T., George P.M. Dietary and supplementary betaine: effects on betaine and homocysteine concentrations in males. Nutr Metab Cardiovasc Dis 2009, 19:767-773.
13. Lawson-Yuen A., Levy H.L. The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab 2006, 88:201-207.
14. Spence J.D. Homocysteine-lowering therapy: a role in stroke prevention?. Lancet Neurol 2007, 6:830-838.
15. Smulders Y.M., Blom H.J. The homocysteine controversy. J Inherit Metab Dis 2011, 34:93-99.
16. Hamelet J., Demuth K., Dairou J., Ledru A., Paul J.L., Dupret J.M., et al. Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice. Biochem Biophys Res Commun 2007, 355:221-227.
17. Kalender Y., Kaya S., Durak D., Uzun F.G., Demir F. Protective effects of catechin and quercetin on antioxidant status, lipid peroxidation and testis-histoarchitecture induced by chlorpyrifos in male rats. Environ Toxicol Pharmacol 2012, 33:141-148.
18. Terao J. Dietary flavonoids as antioxidants. Forum Nutr 2009, 61:87-94.
19. Sakakibara H., Honda Y., Nakagawa S., Ashida H., Kanazawa K. Simultaneous determination of all polyphenols in vegetables, fruits, and teas. J Agric Food Chem 2003, 51:571-581.
20. Vessal M., Hemmati M., Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol Part C 2003, 135:357-364.
21. Annapurna A., Reddy C.S., Akondi R.B., Rao S.R. Cardioprotective actions of two bioflavonoids, quercetin and rutin in experimental myocardial infarction in both normal and streptozotocin-induced type 1 diabetic rats. J Pharm Pharmacol 2009, 61:1365-1374.
22. Zhao L.T., Wu J.Q., Yang J.J., Wei J.Y., Gao W.N., Guo C.J. Dietary quercetin supplementation increase serum antioxidant capacity and alters hepatic gene expression profile in rats. Exp Biol Med 2011, 236:701-706.
23. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76 rodent diet. J Nutr 1993, 123:1939-1951.
24. Velez-Carrasco W., Merkel M., Twiss C.O., Smith J.D. Dietary methionine effects on plasma homocysteine and HDL metabolism in mice. J Nutr Biochem 2008, 19:362-370.
25. Toue S., Kodama R., Amao M., Kawamata Y., Kimura T., Sakai R. Screening of toxicity biomarker for methionine excess in rats. J Nutr 2006, 136:1716s-1721s.
26. Chen C.Y., Milbury P.E., Lapsley K., Blumberg J.B. Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation. J Nutr 2005, 135:1366-1373.
27. Krijt J., Vaková M., Kožich V. Measurement of homocysteine and other aminothiols in plasma: advantages of using tris (2-carboxyethyl) phosphine as reductant compared with tri-n-butylphosphine. Clin Chem 2001, 47:1821-1828.
28. Benzie I.F.F., Strain J.J. The ferric reducing ability of plasma as a measure of antioxidant power: FRAP assay. Anal Biochem 1996, 239:70-76.
29. Ohkawa H., Ohishi N., Kunio Y. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
30. Sundari P.N., Wilfred G., Ramakrishna B. Does oxidative protein damage play a role in the pathogenesis of carbon tetrachloride-induced liver injury in the rat?. Biochim Biophys Acta 1997, 1362:169-176.
31. Levine R.L., Garland D., Oliver C.N., Amici A., Ciment I., Lenz A.G.B., et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990, 186:464-478.
32. Meng B., Gao W.N., Yang J.J., Wei J.Y., Pu L.L., Wu J.Q., et al. Experiment on homocysteinemia in rat induced by high methionine diet. Amino Acids Biotic Resources 2011, 33:57-59.
33. Day A.J., Mellon F., Barron D., Sarrazin G., Morgan M.R.A., Williamson G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 2001, 35:941-952.
34. Egert S., Wolffram S., Bosy-Westphal A., Boesch-Saadatmandi C., Wagner A.E., et al. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 2008, 138:1615-1621.
35. Azuma K., Ippoushi K., Ito H., Higashio H., Terao J. Combination of lipids and emulsifier enhances the absorption of orally administered quercetin in rats. J Agric Food Chem 2002, 50:1706-1712.
36. Azuma K., Ippoushi K., Terao J. Evaluation of tolerable levels of dietary quercetin for exerting its antioxidative effect in high cholesterol-fed rats. Food Chem Toxicol 2010, 48:1117-1122.
37. Su J.F., Guo C.J., Wei J.Y., Yang J.J., Jiang Y.G., Li Y.F. Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin. Biomed Environ Sci 2003, 16:1-8.
38. Molina M.F., Sanchez-Reus I., Iglesias I., Benedi J. Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol Pharm Bull 2003, 26:1398-1402.
39. Dias A.S., Porawski M., Alonso M., Marroni N., Collado P.S., González-Gallego J. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr 2005, 135:2299-2304.
40. Murota K., Hotta A., Ido H., Kawai Y., Moon J.H., Sekido K., et al. Antioxidant capacity of albumin-bound quercetin metabolites after onion consumption in humans. J Med Invest 2007, 54:370-374.
41. Cao G., Sofic E., Prior R.L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 1997, 22:749-760.
42. Boots A.W., Kubben N., Haenen G.R., Bast A. Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation. Biochem Biophys Res Commun 2003, 308:560-565.
43. Boots A.W., Li H., Schins R.P., Duffin R., Heemskerk J.W., Bast A., et al. The quercetin paradox. Toxicol Appl Pharmacol 2007, 222:89-96.